| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.7 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.052 | 0.8 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.06 | 0.8 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |